Press Releases
Fourth Quarter 2025 Highlights
By AerSale Inc · Via GlobeNewswire · March 5, 2026
Completed pre-IND meeting following MGX-001 preclinical data demonstrating curative FVIII activity in non-human primates (NHPs) and remains on track for global regulatory submission including investigational new drug application (“IND”) in 4Q 2026
By Metagenomi, Inc. · Via GlobeNewswire · March 5, 2026
- American Place Casino Continued Its Strong Growth, With Revenues Increasing 13.1% for the Year and 11.0% in the Fourth Quarter
By Full House Resorts, Inc. · Via GlobeNewswire · March 5, 2026
ROGERS, Ark., March 05, 2026 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2026 third quarter financial results on Thursday, March 12, 2026, before the market opens. A webcast and conference call will be held that same day at 9:00 a.m. ET to review the Company’s results.
By America's Car-Mart, Inc. · Via GlobeNewswire · March 5, 2026
SOUTH SAN FRANCISCO, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update, including highlights of pipeline progress.
By TheRas, Inc. (d/b/a BBOT) · Via GlobeNewswire · March 5, 2026
LEBEC, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Tejon Ranch Co., or the Company, (NYSE: TRC), a diversified real estate development and agribusiness company, today announced it will release its fourth quarter and full year 2025 operating and financial results before the market opens on March 19, 2026. In connection with this announcement, the Company will host a conference call on March 19, 2026 at 5:00 p.m. Eastern Time. During the call, President & CEO Matt Walker and CFO Robert Velasquez will provide an update on the Company’s recent initiatives and financial results.
By Tejon Ranch Co · Via GlobeNewswire · March 5, 2026
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
By Nyxoah · Via GlobeNewswire · March 5, 2026
2025, a Transformational Year Marked by Strategic Steps Designed to Enhance Shareholder Value: the Merger with Logan Ridge, Corporate Rebranding and Completion of a Tender Offer
By BCP Investment Corp. · Via GlobeNewswire · March 5, 2026
BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat at the following upcoming investor conference:
By Amneal Pharmaceuticals LLC · Via GlobeNewswire · March 5, 2026
GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H 2026
By CAMP4 Therapeutics · Via GlobeNewswire · March 5, 2026
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outside North America Anticipated Year-End 2026
By Atea Pharmaceuticals, Inc. · Via GlobeNewswire · March 5, 2026
TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today reported financial results for the fourth quarter and full year ended December 31, 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP).
By Profound Medical Corp. · Via GlobeNewswire · March 5, 2026
Company Advances Strategic Transition, Expands IntentKey®, and Provides 2026 Outlook
By Inuvo Inc. · Via GlobeNewswire · March 5, 2026
TARRYTOWN, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation at the Barclays 28th Annual Global Healthcare Conference at 9:00 a.m. ET on Tuesday, March 10, 2026.
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · March 5, 2026
BELTSVILLE, Md., March 05, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer, today provided a business update and reported full year 2025 financial results.
By NextCure · Via GlobeNewswire · March 5, 2026
Simply Home Improvement has unveiled its performance-driven approach to delivering qualified, exclusive leads to home improvement professionals across the United States. The strategy eliminates the traditional pain points that have long plagued contractors seeking consistent work: no shared leads, no ad spend, no setup fees, and no long-term contracts.
Via Get News · March 5, 2026
Revenue up 58% in Fourth Quarter, 53% for Year; Member Growth of 55% for YearAchieves Positive Net Income in Fourth Quarter; Significantly Narrows Net Loss for Full Year Delivers Positive Adjusted EBITDA for Full Year
By Omada Health, Inc. · Via GlobeNewswire · March 5, 2026
MEXICO CITY, March 05, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) reports its February 2026 operational results:
By Grupo Aeroméxico, S.A.B. de C.V. · Via GlobeNewswire · March 5, 2026
Slowdown Studio, a design brand known for its integration of functional art and home decor, recently announced the official launch of its latest product, the Alma Throw woven blanket . Designed by Budapest-based artist Enikő Katalin Eged for the studio, the new woven blanket marks the first release of the 12 winning entries of the annual "Slowdown Art Comp," an annual international competition organized by the studio to discover and elevate contemporary talent.
Via Get News · March 5, 2026
Pattern Group Inc. (NASDAQ: PTRN), a leader in accelerating brands on global ecommerce marketplaces leveraging proprietary technology and AI, today announced financial results for the fourth quarter and full year ended December 31, 2025.
By Pattern Group Inc. · Via Business Wire · March 5, 2026
2PointZero Group PJSC (ADX: 2PointZero), a next-generation investment powerhouse focused on energy and consumer sectors, announced today that it has formally completed the transaction to acquire a majority position in ISEM, a leading European packaging group serving beauty, fashion, luxury, nutraceuticals and more, for AED 704 million through a combination of secondary and primary capital earmarked to accelerate organic and inorganic growth.
By 2PointZero Group PJSC · Via Business Wire · March 5, 2026
LIMASSOL, Cyprus, March 05, 2026 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its preliminary, unaudited financial and operational results for the fourth quarter and twelve months ended December 31, 2025.
By GDEV Inc. · Via GlobeNewswire · March 5, 2026
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Apollo Global Management, Inc. (“Apollo” or the “Company”) (NYSE: APO) securities between May 10, 2021 and February 21, 2026, inclusive (the “Class Period”). Apollo investors have until May 1, 2026 to file a lead plaintiff motion.
By The Law Offices of Frank R. Cruz · Via Business Wire · March 5, 2026
VisualVault, a leading provider of digital information and patient data management solutions, will be exhibiting at the HIMSS Global Health Conference & Exposition, March 9-12 at the Venetian Expo Center in Las Vegas, NV. VisualVault’s presence will be based within the Carahsoft Pavilion, booth 6424.
By VisualVault · Via Business Wire · March 5, 2026
Evommune, Inc. (NYSE: EVMN) (“Evommune” or the “Company”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update.
By Evommune, Inc. · Via Business Wire · March 5, 2026
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announces financial results for the quarter and year ended December 31, 2025, and provides an operational update.
By TriSalus Life Sciences · Via Business Wire · March 5, 2026
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today reported its fourth quarter and full year 2025 financial and operating results and will host a conference call today at 4:30 p.m. Eastern Time to discuss these results and to provide a business update.
By Lineage Cell Therapeutics, Inc. · Via Business Wire · March 5, 2026
ENGLEWOOD, Colo., March 05, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”), a leader in renewable fuels and chemicals as well as carbon management, today announced financial results for the fourth quarter and full year ended December 31, 2025 and provided an update on operating performance, cash flow, and progress across its carbon management and synthetic aviation fuel (“SAF”) growth platform. A quarterly earnings presentation of the financial results will also be posted to the Company’s website at https://investors.gevo.com/news-events/events-presentations.
By Gevo, Inc. · Via GlobeNewswire · March 5, 2026
CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the launch of VANTx™, an AI‑powered, cloud‑native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real‑world evidence development.
By CareDx, Inc. · Via Business Wire · March 5, 2026
Seasoned Life Sciences Executive Joins Galapagos with Strong Track Record in Change Management
By Galapagos NV · Via GlobeNewswire · March 5, 2026
LAS VEGAS, March 05, 2026 (GLOBE NEWSWIRE) -- During a press conference at CONEXPO-CON/AGG 2026, Kawasaki Engines officially launched the production-ready GEOTORQ™, a new series of large spark-ignition engines. Following a successful public preview at Equip Expo 2025, this commercial release marks Kawasaki’s strategic expansion beyond landscape equipment into the "toughest jobs in construction and agriculture."
By Kawasaki Engines · Via GlobeNewswire · March 5, 2026
WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2025.
By OptimizeRx Corporation · Via GlobeNewswire · March 5, 2026
Via PRLog · March 5, 2026
Cheap auto insurance may not provide enough protection when issues occur. Cars can be impounded for many reasons, and retrieving them almost always requires substantial fees. UK Sure Services Ltd offers another solution, with affordable impounded car insurance that makes the process easier and less expensive.
Via Get News · March 5, 2026
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the third quarter ended January 31, 2026, on Thursday, March 12, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 957548. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53731, or by accessing the investors section of the company's website within 72 hours.
Via ACCESS Newswire · March 5, 2026
General Mills (NYSE: GIS) today announced Jonathan Ness has been named Chief Supply Chain Officer, effective March 16, 2026. He will report to Chairman and Chief Executive Officer Jeff Harmening, join the company’s Senior Leadership Team and have accountability for the company's global supply chain operations.
By General Mills · Via Business Wire · March 5, 2026
Kallyope is a late-stage biotechnology company focused on developing innovative migraine and metabolic disease therapies for health challenges faced by hundreds of millions of people globally. Today the Company announced that it will present results from a Phase 2b dose-ranging study of its novel therapy elismetrep in an oral presentation at the 2026 American Academy of Neurology (AAN) Annual Meeting being held April 18-22, 2026 in Chicago, IL. Elismetrep is the only TRPM8 migraine-associated channel blocker (MACB) in late-stage clinical studies for the treatment of migraine.
By Kallyope · Via Business Wire · March 5, 2026
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on March 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 282,000 shares of common stock to seven new employees under the Company’s 2024 Inducement Plan. The Compensation Committee approved the stock options as an inducement material to such employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
By Immunome, Inc. · Via Business Wire · March 5, 2026
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.
By Vertex Pharmaceuticals Incorporated · Via Business Wire · March 5, 2026
New York, NY, March 05, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) (NASDAQ: ACAAU), announced today that the underwriter of its previously announced initial public offering has partially exercised its option to purchase an additional 3,386,008 units at the public offering price of $10.00 per unit, resulting in additional gross proceeds of approximately $33,860,080. The underwriter has a remaining option to purchase up to 363,992 additional units.
By Averin Capital Acquisition Corp. · Via GlobeNewswire · March 5, 2026
TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the fourth quarter and year ended December 31, 2025, and declared a quarterly cash dividend of $0.05 per share.
By Martinrea International Inc. · Via GlobeNewswire · March 5, 2026
In leadership circles, decisions are often reviewed after the fact. Was the strategy sound? Was the data strong? Were the risks calculated correctly?
Via Get News · March 5, 2026
Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) today officially opened its global headquarters in Raleigh, marking an important milestone in the company’s first year as a standalone public company.
By Ralliant Corporation · Via Business Wire · March 5, 2026
Bradenton, FL - The political thriller “The Last Assassin” by Arthur C. Tourkantonis, Sr. has officially launched and is now available on Amazon, drawing readers into a tense world where one retired operative could determine the fate of the President of the United States.
Via Get News · March 5, 2026
ERI, the nation’s leading material resource recovery, ITAD, mobility and data destruction/processing provider and largest recycler of electronics, currently maintains eight zero waste, zero emissions, carbon neutral electronics reuse and recycling facilities, including its state-of-the-art headquarters location in Fresno, California.
By ERI · Via Business Wire · March 5, 2026
FORT LAUDERDALE, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Morgan & Morgan, America’s largest injury law firm, announced today that renowned trial attorney Todd McPharlin has joined the firm’s Fort Lauderdale office as a Trial Partner.
By Morgan & Morgan, P.A. · Via GlobeNewswire · March 5, 2026
Most professionals over the age of 35 don’t wake up one morning and decide they are burned out. It usually starts much earlier and much quieter than that.
Via Get News · March 5, 2026
ZEPHYRHILLS, FL / ACCESS Newswire / March 5, 2026 / Glo Tanning announces the opening of its newest location in Zephyrhills, Florida, on March 7, bringing its signature blend of skincare, wellness, and tanning services to the community.
Via ACCESS Newswire · March 5, 2026
Smart Frames, Voice Remotes and TWS Designs Bring Embodied AI to Everyday Devices
By Syntiant · Via GlobeNewswire · March 5, 2026
RexPayments, a leading global payment processor aggregator trusted by over 2,000 merchants, today announced the launch of Payment Links . This versatile new feature allows businesses to accept payments instantly through shareable, secure URLs, bypassing the need for a complex e-commerce checkout or dedicated website integration.
Via Get News · March 5, 2026